Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer
-
Published:2023-11
Issue:
Volume:194
Page:113321
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Rasola CosimoORCID,
Laurent-Puig PierreORCID,
André ThierryORCID,
Falcoz Antoine,
Lepage ComeORCID,
Aparicio ThomasORCID,
Bouché OlivierORCID,
Lievre Astrid,
Mineur Laurent,
Bennouna Jaafar,
Louvet Christophe,
Bachet Jean Baptiste,
Borg Christophe,
Vernerey Dewi,
Lonardi SaraORCID,
Taieb JulienORCID
Subject
Cancer Research,Oncology
Reference35 articles.
1. Colorectal cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
2. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Argilés;Ann Oncol,2020
3. Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives;Taieb;Cancer Treat Rev,2019
4. Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: a secondary analysis of the AVANT trial;Chibaudel;JAMA Netw Open,2020
5. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial;Taieb;Lancet Oncol,2014